{"id":"ascs","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Pain"},{"rate":"5-10%","effect":"Swelling"},{"rate":"1-5%","effect":"Infection"}]},"_chembl":{"chemblId":"CHEMBL1778796","moleculeType":"Small molecule","molecularWeight":"757.00"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ASCs are derived from a patient's own fat tissue and have the ability to differentiate into various cell types, promoting tissue repair and regeneration.","oneSentence":"ASCs are autologous mesenchymal stem cells used to treat various conditions.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:10:52.821Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cartilage repair"},{"name":"Orthopedic conditions"}]},"trialDetails":[{"nctId":"NCT06905834","phase":"PHASE2","title":"Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2026-05","conditions":"Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD)","enrollment":30},{"nctId":"NCT07431099","phase":"NA","title":"Skin Color Matching in Head and Neck Reconstructive Surgery","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-03","conditions":"Head and Neck Cancer","enrollment":20},{"nctId":"NCT06840275","phase":"PHASE2","title":"ASCs in Recently Diagnosed Non-ischemic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Cell to Cure ApS","startDate":"2026-03-01","conditions":"Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure","enrollment":90},{"nctId":"NCT02375802","phase":"PHASE1","title":"Adipose-Derived Stromal Cells (ASC's) for Pressure Ulcers","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2015-07","conditions":"Pressure Ulcer","enrollment":12},{"nctId":"NCT06592703","phase":"PHASE1","title":"Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis","status":"RECRUITING","sponsor":"Rennes University Hospital","startDate":"2025-03-06","conditions":"Multiple Sclerosis","enrollment":10},{"nctId":"NCT05595681","phase":"PHASE1","title":"Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.","status":"TERMINATED","sponsor":"Cell to Cure ApS","startDate":"2022-12-15","conditions":"Diabetic Foot Ulcer, Mesenchymal Stromal Cells","enrollment":21},{"nctId":"NCT06843122","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL)","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-03-08","conditions":"Diabetic Foot Ulcer","enrollment":105},{"nctId":"NCT06045416","phase":"","title":"Borrelia B-cell Diagnostics","status":"RECRUITING","sponsor":"University Children's Hospital, Zurich","startDate":"2024-04-02","conditions":"Lyme Disease, Borrelia Infections","enrollment":502},{"nctId":"NCT05610865","phase":"PHASE1","title":"Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers","status":"RECRUITING","sponsor":"University of the Punjab","startDate":"2020-11-20","conditions":"Diabetic Foot Ulcer, Diabetes Mellitus, Diabetic Foot","enrollment":28},{"nctId":"NCT05610878","phase":"PHASE1","title":"Efficacy of Preconditioned Adipose-Derived Stem Cells in Fat Grafting","status":"RECRUITING","sponsor":"University of the Punjab","startDate":"2020-11-20","conditions":"Romberg Disease, Craniofacial Microsomia, Burn Scar","enrollment":24},{"nctId":"NCT05602116","phase":"PHASE1","title":"ASC - Autism Study","status":"COMPLETED","sponsor":"Cell to Cure ApS","startDate":"2023-06-09","conditions":"Autism Spectrum Disorder, Gastrointestinal Dysfunction, Leaky Gut Syndrome","enrollment":10},{"nctId":"NCT03613636","phase":"","title":"Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP)","status":"COMPLETED","sponsor":"University Children's Hospital, Zurich","startDate":"2016-05-01","conditions":"Childhood Pneumonia, Mycoplasma Pneumonia, Antibody-secreting Cells","enrollment":490},{"nctId":"NCT03878628","phase":"EARLY_PHASE1","title":"Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2019-10-16","conditions":"Dry Eye, Kerato Conjunctivitis Sicca, Aqueous Tear Deficiency","enrollment":7},{"nctId":"NCT04420416","phase":"","title":"Mental Health and Academic Performance in COVID-19","status":"COMPLETED","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2020-04-01","conditions":"Depression, Anxiety","enrollment":720},{"nctId":"NCT04776538","phase":"PHASE2","title":"Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2021-02-09","conditions":"Xerostomia Following Radiotherapy","enrollment":120},{"nctId":"NCT03968198","phase":"PHASE2","title":"Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia.","status":"TERMINATED","sponsor":"University Hospital, Toulouse","startDate":"2020-03-04","conditions":"Critical Limb Ischemia and Peripheral Artery Disease","enrollment":2},{"nctId":"NCT04615455","phase":"PHASE2","title":"Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2020-11-03","conditions":"Keratoconjunctivitis Sicca, in Sjogren's Syndrome","enrollment":40},{"nctId":"NCT05079243","phase":"NA","title":"Dermal and Subcutaneous Augmentation and Skin Assessment After Fat-, Stem Cell and Scaffold Injections","status":"UNKNOWN","sponsor":"Stemform","startDate":"2021-06-04","conditions":"Augmentation, Reconstruction","enrollment":5},{"nctId":"NCT04503161","phase":"NA","title":"The Effect of an ASC-seeded Collagen Hydrogel on Cerebrospinal Fluid Leak Rates Following Skull Base Surgery","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2021-09","conditions":"CSF Leak","enrollment":""},{"nctId":"NCT05484856","phase":"PHASE1, PHASE2","title":"Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA)","status":"COMPLETED","sponsor":"Dr. Himanshu Bansal Foundation","startDate":"2016-05-16","conditions":"Osteoarthritis, Knee","enrollment":140},{"nctId":"NCT04340284","phase":"PHASE1, PHASE2","title":"Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion","status":"COMPLETED","sponsor":"Dr. Himanshu Bansal Foundation","startDate":"2019-11-10","conditions":"Nonunion of Fracture","enrollment":11},{"nctId":"NCT05239416","phase":"NA","title":"Fat Grafting in Reducing Recurrence in Patients With Healed Venous Ulcers A Prospective Randomised Clinical Pilot Study","status":"UNKNOWN","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2022-02","conditions":"Varicose Ulcer","enrollment":20},{"nctId":"NCT03920397","phase":"NA","title":"Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2015-03-01","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT02092870","phase":"PHASE2","title":"Adipose Derived Regenerative Cellular Therapy of Chronic Wounds","status":"COMPLETED","sponsor":"Tower Outpatient Surgical Center","startDate":"2013-09","conditions":"Diabetic Foot, Venous Ulcer, Pressure Ulcer","enrollment":25},{"nctId":"NCT01020825","phase":"","title":"Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled Trial","status":"COMPLETED","sponsor":"Tigenix S.A.U.","startDate":"2008-09","conditions":"Complex Perianal Fistula","enrollment":148},{"nctId":"NCT00475410","phase":"PHASE3","title":"Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease","status":"COMPLETED","sponsor":"Tigenix S.A.U.","startDate":"2007-02","conditions":"Anal Fistula","enrollment":214},{"nctId":"NCT01378390","phase":"PHASE3","title":"Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease","status":"TERMINATED","sponsor":"Tigenix S.A.U.","startDate":"2008-12","conditions":"Complex Perianal Fistula, Crohn Disease","enrollment":56},{"nctId":"NCT01924364","phase":"NA","title":"Effect of Concentrating Endogenous Stromal Cells in the Fat Graft Using TGI Device","status":"COMPLETED","sponsor":"J. Peter Rubin, MD","startDate":"2012-06-30","conditions":"Facial Injuries, Tissue Injury","enrollment":7},{"nctId":"NCT01803347","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells","status":"COMPLETED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2013-02","conditions":"Anal Fistula","enrollment":80},{"nctId":"NCT01453751","phase":"NA","title":"Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes","status":"WITHDRAWN","sponsor":"Ageless Regenerative Institute","startDate":"2014-03","conditions":"Diabetes Mellitus Type II","enrollment":""},{"nctId":"NCT01645722","phase":"NA","title":"Enriched Autologous Fat Grafting for Treating Pain at Amputation Sites","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2012-07","conditions":"Amputation Stumps, Pain","enrollment":5},{"nctId":"NCT01453816","phase":"NA","title":"Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Renal Failure","status":"WITHDRAWN","sponsor":"Ageless Regenerative Institute","startDate":"2011-05","conditions":"Renal Failure","enrollment":""},{"nctId":"NCT01974128","phase":"NA","title":"Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction","status":"WITHDRAWN","sponsor":"Ageless Regenerative Institute","startDate":"2014-10","conditions":"Acute Myocardial Infarction","enrollment":""},{"nctId":"NCT01502501","phase":"NA","title":"Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure","status":"WITHDRAWN","sponsor":"Ageless Regenerative Institute","startDate":"2011-05","conditions":"Non-Ischemic Congestive Heart Failure","enrollment":""},{"nctId":"NCT01453829","phase":"PHASE1, PHASE2","title":"Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke","status":"WITHDRAWN","sponsor":"Ageless Regenerative Institute","startDate":"2014-10","conditions":"Stroke","enrollment":""},{"nctId":"NCT01211028","phase":"PHASE1, PHASE2","title":"Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2009-01","conditions":"Peripheral Vascular Diseases, Cardiovascular Diseases","enrollment":13},{"nctId":"NCT03113747","phase":"PHASE1, PHASE2","title":"Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)","status":"UNKNOWN","sponsor":"A.A. Partners, LLC","startDate":"2015-03-25","conditions":"Second- or Third-degree Burns","enrollment":20},{"nctId":"NCT01157650","phase":"PHASE1, PHASE2","title":"Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue","status":"COMPLETED","sponsor":"Clinica Universidad de Navarra, Universidad de Navarra","startDate":"2010-06","conditions":"Crohn Disease","enrollment":15},{"nctId":"NCT01564524","phase":"","title":"Effect of Concentrating Endogenous Stromal Cells in the Fat Graft","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2011-04","conditions":"Facial Injuries, Adipose Tissue","enrollment":3},{"nctId":"NCT01795950","phase":"PHASE1","title":"Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)","status":"TERMINATED","sponsor":"United Therapeutics","startDate":"2013-04","conditions":"Pulmonary Arterial Hypertension","enrollment":6},{"nctId":"NCT02403232","phase":"PHASE2","title":"Autologous Adipose-derived Stem Cells (ASCs) for the Treatment of Perianal Fistula in Crohn Disease: A Pilot Study","status":"UNKNOWN","sponsor":"Papa Giovanni XXIII Hospital","startDate":"2014-12","conditions":"Perianal Fistula, Crohn Disease","enrollment":10},{"nctId":"NCT01914887","phase":"PHASE1, PHASE2","title":"Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis","status":"UNKNOWN","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2013-06","conditions":"Ulcerative Colitis","enrollment":8},{"nctId":"NCT00919958","phase":"PHASE1","title":"Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia","status":"COMPLETED","sponsor":"Pluristem Ltd.","startDate":"2009-06","conditions":"Peripheral Artery Disease, Peripheral Vascular Disease, Critical Limb Ischemia","enrollment":15},{"nctId":"NCT00999115","phase":"PHASE1, PHASE2","title":"Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn's Disease (ALOREVA)","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz","startDate":"2009-09","conditions":"Rectovaginal Fistula, Crohn Disease","enrollment":10},{"nctId":"NCT00115466","phase":"PHASE2","title":"Autologous Stem Cells Derived From Lipoaspirates for the Non-Surgical Treatment of Complex Perianal Fistula","status":"UNKNOWN","sponsor":"Cellerix","startDate":"2004-10","conditions":"Anal Fistula","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5575,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cx401 (company code)","Ontaril®","Allogeneic adipose-derived mesenchymal stem cells"],"phase":"phase_2","status":"active","brandName":"ASCs","genericName":"ASCs","companyName":"Tigenix S.A.U.","companyId":"tigenix-s-a-u","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ASCs are autologous mesenchymal stem cells used to treat various conditions. Used for Cartilage repair, Orthopedic conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}